Adverse events of biological agents in pediatric rheumatologic diseases.
Merve Cansu PolatSaniye MertekZeynep Birsin ÖzçakarElif ÇelikelFatma AydınZahide Ekinci TekinAtilla Halil ElhanBanu Çelikel AcarNilgun ÇakarPublished in: Postgraduate medicine (2024)
The physician should be vigilant for latent TB in patients exposed to BA for more than 2 years. While local skin reactions are more prevalent in patients receiving anti-IL1, severe skin reactions such as DRESS may also occur.